Pertussis clinical trials

Explore recruiting pertussis clinical trials.

Recruiting pertussis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pertussis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Maternal pertussis immunization in Finland, 4 years (MIFI-4Y)

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety and immunogenicity of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers

Italy, Poland, Finland, Netherlands, Greece, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

dTap booster vaccination of health care workers (HC dTap)

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Maternal determinants of infant immunity to pertussis (MADI-02)

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A phase 4, randomised vaccination study in healthy adults to investigate the effects of acellular pertussis vaccine on colonisation with Bordetella pertussis using controlled human infection (KIM-study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATIMMUNE)

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Pertussis trials by city

Pertussis in Toronto Pertussis in Vancouver Pertussis in Montreal Pertussis in Calgary Pertussis in Edmonton Pertussis in Ottawa Pertussis in Winnipeg Pertussis in Quebec City Pertussis in Hamilton Pertussis in Kitchener Pertussis in London Pertussis in Halifax Pertussis in New York Pertussis in Los Angeles Pertussis in Chicago Pertussis in Houston

Pertussis clinical trials

Recruiting pertussis studies right now

Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

Also recruiting in Europe

Maternal pertussis immunization in Finland, 4 years (MIFI-4Y)

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety and immunogenicity of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers

dTap booster vaccination of health care workers (HC dTap)

Maternal determinants of infant immunity to pertussis (MADI-02)

A phase 4, randomised vaccination study in healthy adults to investigate the effects of acellular pertussis vaccine on colonisation with Bordetella pertussis using controlled human infection (KIM-study)

The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATIMMUNE)

Pertussis trials by city

Other conditions